188 Participants Needed

Digital CBTI for Chronic Insomnia

AG
MW
Overseen ByMegan Wolfson, LCSW
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Noctem, LLC
Must be taking: Prescribed sleep medications
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial compares two treatments for chronic insomnia: a digital version of Cognitive Behavioral Therapy for Insomnia (CBTI) using a smartphone app, specifically COAST-enhanced CBTI, and the usual care at military treatment centers. Researchers aim to determine if the digital method is as effective as standard care in improving sleep, reducing depression and anxiety, and increasing satisfaction with the treatment. Active-duty military members with diagnosed chronic insomnia who are stable on any sleep medications and own a smartphone might be suitable candidates. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance insomnia treatment options.

Do I need to stop my current medications to join the trial?

The trial does not specify that you need to stop your current medications. However, if you are using prescribed sleep medications, you must have been on a stable dosage for at least 4 weeks and have no planned changes during the trial.

What prior data suggests that this digital platform for CBTI is safe for treating insomnia?

Research has shown that Cognitive Behavioral Therapy for Insomnia (CBTI) safely and effectively treats long-term sleep problems. Many studies have found that it significantly improves sleep and reduces anxiety and depression. Digital versions of CBTI, such as COAST-enhanced CBTI, are also popular. These versions have helped people sleep better and feel more satisfied with their treatment.

Participants using digital CBTI often adhere to the program, indicating its ease of use and accessibility. The American Academy of Sleep Medicine recommends CBTI as the first choice for treating adults with chronic insomnia, underscoring its strong safety and effectiveness. Overall, digital CBTI appears to be a well-accepted option for treating insomnia.12345

Why are researchers excited about this trial?

Researchers are excited about COAST-enhanced CBTI for chronic insomnia because it leverages digital technology to provide Cognitive Behavioral Therapy for Insomnia (CBTI) through a smartphone app, making treatment more accessible and engaging. Unlike traditional in-person therapy sessions, this method allows for real-time interaction with licensed clinicians via NOCTEM's digital sleep hub, which can enhance adherence and personalization of treatment. This innovative approach not only offers convenience but also integrates digital tools for monitoring progress, potentially leading to more effective and tailored insomnia care.

What evidence suggests that this trial's treatments could be effective for chronic insomnia?

Studies have shown that Cognitive Behavioral Therapy for Insomnia (CBT-I) is as effective as sleep medication for improving sleep, but without the side effects. Research indicates that digital tools and AI combined with CBT can significantly enhance sleep quality, treatment adherence, and satisfaction. Additionally, remote CBT for insomnia has improved sleep and mental health, and it can also alleviate depression and anxiety symptoms. In this trial, participants in the COAST-enhanced CBTI arm will receive therapy through a digital platform, which is expected to effectively treat insomnia and related issues. Meanwhile, participants in the Military Treatment Facility Insomnia Care As Usual arm will receive standard insomnia care from a certified clinician at their respective site.12567

Who Is on the Research Team?

AG

Anne Germain

Principal Investigator

Noctem, LLC

Are You a Good Fit for This Trial?

This trial is for active duty service members aged 18 or older who have chronic insomnia and are cleared for Cognitive Behavioral Treatment of Insomnia (CBTI). They must not have any serious health issues that could affect their safety, and if they're taking sleep meds, the dose must be stable for at least 4 weeks. Participants also need a recent smartphone.

Inclusion Criteria

I am an active duty service member diagnosed with chronic insomnia and eligible for CBTI.
Absence of, or stable, psychiatric, or medical comorbidity(ies), such that they do not compromise safety when completing study procedures
Owning or ability to use a smartphone (iPhone or Android) that is no older than 5 years old (e.g., iPhone 6, and Android phone with Lollipop 5.0 mobile operating system)
See 1 more

Exclusion Criteria

Currently pregnant, breastfeeding, or being the parent of a newborn < 3 months old
Having planned or attempted suicide or the harming of others in the past 6 months
Past or current psychotic or bipolar disorder or sub-threshold symptoms of psychotic or bipolar disorders
See 8 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either COAST-enhanced CBTI or insomnia care as usual

6-8 weeks
Regular virtual check-ins via the COAST platform or in-person visits for ICAU

Follow-up

Participants are monitored for changes in insomnia severity, depression, and anxiety symptoms

3 months
Follow-up assessments at 3 months

What Are the Treatments Tested in This Trial?

Interventions

  • COAST-enhanced CBTI
  • Military Treatment Facility Insomnia Care As Usual
Trial Overview The study compares traditional insomnia care at military facilities with a new digital platform called COAST-enhanced CBTI to see which is better for treating insomnia, depression, anxiety symptoms, and patient satisfaction.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: COAST-enhanced CBTIActive Control1 Intervention
Group II: Military Treatment Facility Insomnia Care As UsualActive Control1 Intervention

COAST-enhanced CBTI is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Cognitive Behavioral Therapy for Insomnia for:
🇪🇺
Approved in European Union as Cognitive Behavioral Therapy for Insomnia for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Noctem, LLC

Lead Sponsor

Trials
3
Recruited
370+

Published Research Related to This Trial

Cognitive behavioral therapy for insomnia (CBTi) is a highly effective non-drug treatment for insomnia, showing comparable efficacy to sleep medications in randomized control trials, with better long-term maintenance of benefits after treatment ends.
Due to its strong empirical support, both the National Institutes of Health and the American Academy of Sleep Medicine recommend CBTi as the standard treatment for insomnia, highlighting its importance in addressing the public health burden of this condition.
Insomnia and its effective non-pharmacologic treatment.Siebern, AT., Manber, R.[2018]
Digital cognitive behavioral therapy (dCBT) significantly improves functional health, psychological well-being, and sleep-related quality of life in individuals with insomnia, based on a study of 1711 participants over 24 weeks.
The reduction in insomnia symptoms was a key factor mediating these improvements, highlighting that dCBT effectively addresses both daytime and nighttime issues related to poor sleep.
Effect of Digital Cognitive Behavioral Therapy for Insomnia on Health, Psychological Well-being, and Sleep-Related Quality of Life: A Randomized Clinical Trial.Espie, CA., Emsley, R., Kyle, SD., et al.[2023]
The Veterans Health Administration developed a digital mental health intervention called Path to Better Sleep (PTBS) to provide accessible cognitive behavioral therapy for insomnia (CBT-I) to veterans, addressing the shortage of trained providers.
Feedback from veteran and spouse evaluation panels significantly influenced the design of PTBS, leading to improvements in user engagement by emphasizing CBT-I efficacy, simplifying content, and incorporating relatable veteran testimonials.
The Use of Evaluation Panels During the Development of a Digital Intervention for Veterans Based on Cognitive Behavioral Therapy for Insomnia: Qualitative Evaluation Study.Ryan, AT., Brenner, LA., Ulmer, CS., et al.[2023]

Citations

Cognitive-Behavioral Therapy for Insomnia: An Effective ...CBT-i produces results that are equivalent to sleep medication, with no side effects, fewer episodes of relapse, and a tendency for sleep to continue to improve ...
Digital and AI-Enhanced Cognitive Behavioral Therapy for ...Results: The findings suggest that digital and AI-enhanced CBT significantly improves sleep parameters, patient adherence, satisfaction, and the personalization ...
Nurse-Supported Self-Directed Cognitive Behavioral ...Main Outcomes and Measures The primary outcome was the Insomnia Severity Index (score range, 0-28; remission <8; differential improvement of 3 ...
Cognitive Behavioral Therapy for Insomnia (CBT-I): A PrimerFinally, one study showed that CBT-I could even be effective in treating insomnia among “real world” patients (i.e., those with comorbid medical and behavioral ...
Efficacy of Remote Cognitive Behavioural Therapy for ...Remote cognitive behavioural therapy for insomnia is effective in improving sleep quality, depression, anxiety, fatigue and mental health in insomnia patients.
Digital cognitive behavioral therapy for insomniaThe AASM recommends clinicians use cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment for chronic insomnia in adults.
Enhancing behavioral sleep care with digital technologyCBTI has been shown to be effective for chronic insomnia, including insomnia that is comorbid with PTSD, anxiety, depression, alcohol and ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security